Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Editorial

Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes

  1. Peter C. Butler
  1. From the Division of Endocrinology, Larry L. Hillblom Islet Research Center, University of California, Los Angeles, Los Angeles, California
  1. Corresponding author: Peter C. Butler, pbutler{at}mednet.ucla.edu.
Diabetes 2011 Dec; 60(12): 3099-3099. https://doi.org/10.2337/db11-1127
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

This December 2011 edition of Diabetes marks the completion of the 5-year term of the outgoing editorial team. It has been my honor and pleasure to serve as editor with such a dedicated and accomplished team of associate editors. I thank each of them for their gift of time, their patience, their scholarship, their integrity, and their good humor. We would also like to collectively thank Edwin Gale, the former editor in chief of Diabetologia and Mayer Davidson, former editor in chief of Diabetes Care, who both gave us generous and useful advice as we took on the task of editing Diabetes. We would also like to thank the editorial staff at the University of California, Los Angeles, and at the American Diabetes Association office in Indiana, for assisting us in striving to give submitting authors a timely decision, even if not always one they wanted.

As Diabetes now moves forward under the guidance of the new editorial team led by K. Sreekumaran Nair at the Mayo Clinic, we wish the new team the very best. They are an impressive group of talented researchers that will bring new energy and new ideas to the journal. The outgoing editorial team congratulates them for agreeing to take on this ever more complex task. Oscar Wilde said, “The truth is rarely pure and never simple.” With the rapid expansion in the complexity of available research tools that generate vast quantities of data, the separation of truth from artifact becomes ever more of a challenge for scientists and editors alike. The advances in technology also apply to the publication process itself. With the rapidly changing landscape of how information is published and how information is accessed, no publication can afford to stand still. The emerging electronic publishing environment offers tremendous opportunities for a publication with a leadership position in the field such as Diabetes but, equally, some hazards. The relative fate of Yahoo and Google illustrates how rapidly established leadership can be challenged in this era of predominance for online electronic dissemination and access of information. It will therefore be important that the impressive new editorial team is matched by a comparable commitment by the American Diabetes Association to match the editors’ ambitions for the journal. Increased sophistication in publication will certainly be required to stay in the forefront of electronic publications.

Some important steps have already been taken by the American Diabetes Association in this regard, including the use of screening tools to examine submitted manuscripts for plagiarism and inappropriate adjustments of figures. It is a concern how frequently attempted fraud in publication has been detected in the last few years, most often not by the electronic screening devices but by astute peer review. Every scientist has a story to tell about the errors of their peers in failing to support their superb manuscript. As an editor in chief, one regularly receives mail to that effect, some of it quite robust in the stated opinions, which often extend to the editor's own shortcomings. While I fully acknowledge the shortcomings of the outgoing editor in chief, after 5 years of watching over the traffic of many thousands of manuscripts, I have developed a renewed respect for scientific peer review. It is remarkable how often three reviews are concordant. Regular reviewers for Diabetes are typically generous in the detail and time they offer the submitting authors by way of constructive suggestions. It is interesting that those that complain the most about the peer review process are often those that most often decline to provide peer review. Also, when authors complained that we “had obviously selected the reviewers designated as nonpreferred since the reviews were recognizable as expressing the expected bias,” we had actually most often selected their preferred reviewers.

So as a final thank you, I want to particularly acknowledge the peer reviewers who are so critical to the quality of the articles in Diabetes. Thank you for agreeing to review when you have, thank you for the gift of your time and scholarship in preparing your constructive critiques, and thank you for your flexibility in being accommodating to the collective advice of the other reviewers and the responses of the authors. For all its shortcomings, peer review works well most of the time. It perhaps deserves a similar tribute as that offered by Winston Churchill about democracy: “Democracy is the worst form of government except all the others that have been tried.”

  • © 2011 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

View Abstract
PreviousNext
Back to top
Diabetes: 60 (12)

In this Issue

December 2011, 60(12)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes
Peter C. Butler
Diabetes Dec 2011, 60 (12) 3099; DOI: 10.2337/db11-1127

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes
Peter C. Butler
Diabetes Dec 2011, 60 (12) 3099; DOI: 10.2337/db11-1127
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Call for Improved Reporting of Human Islet Characteristics in Research Articles
  • Eulogy for the Metabolic Clinical Investigator?
  • Summary of the Keystone Islet Workshop (April 2014): The Increasing Demand for Human Islet Availability in Diabetes Research
Show more Editorial

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.